A comparison of the prediction accuracy of two IVIVC modelling techniques.

The goal when developing an in vitro-in vivo correlation (IVIVC) model is the ability to accurately predict the in vivo plasma concentration profile of a drug formulation using only its in vitro dissolution data. The prediction accuracy of any model depends on the reliability of the method used to develop it. Some statistical concerns regarding methods based on deconvolution have been highlighted and a convolution based technique has been proposed as an alternative. This comparison shows, by means of a simulation study, that the modelling approach which uses convolution produces far more accurate results, accurately predicting the observed plasma concentration-time profile and, therefore, comfortably meeting the FDA validation criteria. The fact that the model developed using the deconvolution based technique fails to describe the simulated data and thus fails the FDA validation test when it ought to pass should be of great concern to those currently implementing this method.

[1]  Ying Liu,et al.  A Multi‐mechanistic Drug Release Approach in a Bead Dosage Form and In Vitro/In Vivo Correlations , 2003, Pharmaceutical development and technology.

[2]  K R Godfrey,et al.  CODE: a deconvolution program implementing a regularization method of deconvolution constrained to non‐negative values. Description and pilot evaluation , 1998, Biopharmaceutics & drug disposition.

[3]  G. Molenberghs,et al.  Linear Mixed Models for Longitudinal Data , 2001 .

[4]  G. Wing,et al.  A Primer on Integral Equations of the First Kind: The Problem of Deconvolution and Unfolding , 1987 .

[5]  R Abuzarur-Aloul,et al.  Critical dissolution tests of oral systems based on statistically designed experiments. II. In vitro optimization of screened variables on ER-coated spheres for the establishment of an in vitro/in vivo correlation. , 1998, Drug development and industrial pharmacy.

[6]  J Mikkola,et al.  Development of level A, B and C in vitro-in vivo correlations for modified-release levosimendan capsules. , 2002, International journal of pharmaceutics.

[7]  R Abuzarur-Aloul,et al.  Critical dissolution tests of oral systems based on statistically designed experiments. III. In vitro/in vivo correlation for multiple-unit capsules of paracetamol based on PLS modeling. , 1998, Drug development and industrial pharmacy.

[8]  John Davis,et al.  Deconvolution Based Approach for Level A In Vivo-In Vitro Correlation Modelling: Statistical Considerations , 2005 .

[9]  Lewis B. Sheiner,et al.  Simultaneous vs. Sequential Analysis for Population PK/PD Data I: Best-Case Performance , 2003, Journal of Pharmacokinetics and Pharmacodynamics.

[10]  C. Farrell,et al.  IVIVC for Oral Drug Delivery: Immediate Release and Extended Release Dosage Forms , 2007 .

[11]  A. Dunne,et al.  In Vivo–In Vitro Correlation (IVIVC) Modeling Incorporating a Convolution Step , 2001, Journal of Pharmacokinetics and Pharmacodynamics.

[12]  G. W. Snedecor.  Statistical Methods , 1964 .

[13]  R. Abuzarur-Aloul,et al.  Critical dissolution tests of oral systems based on statistically designed experiments. I. Screening of critical fluids and in vitro/in vivo modelling of extended release coated spheres , 1997 .

[14]  Keith R. Godfrey,et al.  A comparison of six deconvolution techniques , 1996, Journal of Pharmacokinetics and Biopharmaceutics.

[15]  Adrian Dunne.  Approaches to Developing In Vitro–In Vivo Correlation Models , 2007 .